STOCKGAINERSS and 3 other desks issued 5 swing trade recommendations targeting 2–5 day holding periods on broadly bullish chart setups.
STOCKGAINERSS and 3 other registered desks issued 10 equity swing recommendations today, targeting price setups over a 2 to 5 day holding window. The batch carries a bullish bias — 10 buys against 0 sells — covering 5 stocks.
STARHEALTH attracted 4 separate recommendations from registered analysts — STOCKGAINERSS issued a buy at ₹789 targeting ₹850 (stop ₹740); STOCKGAINERSS issued a buy at ₹789 targeting ₹950 (stop ₹740); STOCKGAINERSS issued a buy at ₹760 targeting ₹850 (stop ₹740); STOCKGAINERSS issued a buy at ₹760 targeting ₹950 (stop ₹740).
DREDGECORP was flagged for a buy by Motilaloswalofficial at ₹1,184.65, targeting ₹1,239.95 — a potential upside of +4.7%, with a stoploss at ₹1,157. The risk-to-reward ratio stands at 1:2.0.
MINDTECK attracted 2 separate recommendations from registered analysts — Elitewealthltd issued a buy at ₹218 targeting ₹230 (stop ₹207); Elitewealthltd issued a buy at ₹218 targeting ₹240 (stop ₹207).
Also covered: SASKEN (₹2,120 → ₹2,180) via STOCKGAINERSS; SONACOMS (₹612 → ₹651) via Icms1.
Swing positions are typically held for two to five sessions. Track broader index levels and avoid holding through major macro events without adjusting stoplosses.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.